Francis, Grodon <br/><br/>
Re: Vartanian T. An examination of the results of the EVIDENCE, INCOMIN, and phase III studies of interferon beta products in the treatment of multiple sclerosis. Clin Ther. 2003;25:105-118.  [electronic resource] 

 -  Clinical therapeutics  Jun 2003 
 - 1888-90 p.  digital 
<br/><br/> Publication Type: Comment; Comparative Study; Letter 
<br/><br/><label>ISSN: </label>0149-2918 
<br/><br/><label>Standard No.: </label>10.1016/s0149-2918(03)90030-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials, Phase III as Topic<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Humans<br/>Interferon beta-1a<br/>Interferon-beta--therapeutic use<br/>Magnetic Resonance Imaging--methods<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Randomized Controlled Trials as Topic<br/>Treatment Outcome